{"id":279,"date":"2025-04-21T15:52:04","date_gmt":"2025-04-21T19:52:04","guid":{"rendered":"https:\/\/pravanfoundation.org\/?p=279"},"modified":"2025-04-25T16:08:05","modified_gmt":"2025-04-25T20:08:05","slug":"from-recreation-to-rehabilitation-exploring-the-therapeutic-potential-of-psychedelics","status":"publish","type":"post","link":"https:\/\/pravanfoundation.org\/en\/from-recreation-to-rehabilitation-exploring-the-therapeutic-potential-of-psychedelics\/","title":{"rendered":"From Recreation to Rehabilitation: Exploring the Therapeutic Potential of Psychedelics"},"content":{"rendered":"

[vc_section full_width=”stretch_row”][vc_row full_width=”stretch_row”][vc_column][vc_column_text el_class=”grey has-tables”]Get ready to dive deep into the intriguing world of psychedelic-assisted therapies, which are generating plenty of buzz in the mental health landscape. While we’ve only begun to scratch the surface of their potential, emerging research suggests psychedelics, including MDMA, ketamine, psilocybin, and LSD, may offer relief for various mental health conditions in a therapeutic setting.<\/p>\n

Therapy with substance or Psychedelic-assisted therapy not only relies on the substance as a \u201ccure-all\u201d approach, rather the substance allows space for the therapy to delve into repressed, stuck or uncharted emotional waters. Psychedelic-assisted therapy (PAT), borrows from numerous therapeutic modalities. Drawing from eclectic techniques such as Internal Family Systems, somatic trauma therapies, and trauma-focused therapies, each approach aims to enhance psychological flexibility and deepen the spiritual, emotional, intellectual and\u00a0 biomechanical effects of psychedelics.<\/p>\n

In a time where traditional treatments often fall short, researchers are turning over every stone, and in this case, that stone might just be a “magic” mushroom.<\/p>\n

MDMA (3,4-methylenedioxymethamphetamine):<\/h2>\n

Perhaps best known for its recreational use, is reemerging in the spotlight as a potential ally in the fight against PTSD. MDMA, often known as ecstasy, falls under a category called enactogens or empathogens. MDMA influences several neurochemical systems, including serotonin, dopamine, norepinephrine, cortisol, and oxytocin. In the controlled, nurturing environment of therapy, MDMA could assist by unlocking a profound emotional openness, reducing fear and defensiveness, and facilitating trust. It’s like the bridge that could reconnect patients with therapists, potentially leading to significant reductions in PTSD symptoms.<\/p>\n

MDMA-assisted therapies have shown particularly promising results in the treatment of post-traumatic stress disorder (PTSD), especially among war veterans. This population faces a silent crisis: according to the U.S. Department of Veterans Affairs, an average of 22 veteran suicides per day were reported in 2010, and although that number decreased to 20 per day in 2014, it still represents an alarming reality. In recent studies, up to 71% of patients who underwent MDMA-assisted therapy no longer met the diagnostic criteria for PTSD. These outcomes have inspired significant hope within the medical community and among those living with the disorder. However, it is important to emphasize that the FDA has not yet granted final approval for its clinical use.<\/p>\n

Ketamine<\/h2>\n

\"\"
\nKetamine, belonging to the family of dissociative anesthetics, can induce psychedelic effects at lower, non-anesthetic doses. Originally an anesthetic, ketamine is breaking barriers in treating depression, addiction, obsessive compulsive disorder (OCD), and PTSD. Its mechanisms are intriguing: blocking NMDA receptors, activating AMPA receptors, which in turn enhance synaptic plasticity and help control how your neurons, or brain cells, communicate with each other, especially in processes like learning and memory.<\/p>\n

This unlikely hero has shown rapid antidepressant effects, creating new neural connections, kind of like rewiring a circuit board. But just like the precision required in electronics, we must approach Ketamine therapy with vigilance, considering long-term efficacy, safety, and optimal dosing protocols.<\/p>\n

Psilocybin<\/h2>\n

\"\"<\/p>\n

The magic ingredient in certain species of mushrooms. Recently, it’s been showing promise in treating depression, anxiety, obsessive-compulsive disorder, and substance use disorders, and even end-of-life distress.<\/p>\n

Working its magic on the serotonin system – serotonin 5-HT2A receptors, Psilocybin can promote neuroplasticity, enhance psychological flexibility, boost creativity, foster mindfulness, and encourage social connectedness. By inducing mystical experiences and shifting metaphysical beliefs, these substances may infuse life with renewed meaning and promote positive behavioral changes.<\/p>\n

LSD (lysergic acid diethylamide):<\/h2>\n

A compound known for its dramatic effects on perception, cognition, and emotions. Although its therapeutic potential is still being uncovered, early hints suggest that LSD-assisted therapy might offer benefits in treating addiction, anxiety, and depression.\u00a0 LSD acts on numerous serotonin receptors, altering neural activity and promoting altered states of consciousness, LSD could potentially add another dimension to therapy.<\/p>\n

To make it easier to compare these substances at a glance, take a look at this overview guide of the uses, neuroscientific effects, experience and contraindications of each (resource: Beckley Academy; Foundations of Psychedelic Assisted Therapy<\/a>. Module 3):<\/p>\n

Effective and Promising Uses<\/h2>\n\n\n\n\n
Ketamine\u00a0<\/b><\/td>\nPsilocybin<\/b><\/td>\n MDMA<\/b><\/td>\n<\/tr>\n
\n
    \n
  • Anti-depressant effects<\/li>\n
  • Reduction of suicidal<\/li>\n<\/ul>\n

    thoughts<\/p>\n

      \n
    • PTSD<\/li>\n
    • Anxiety disorders<\/li>\n
    • Substance use disorders<\/li>\n<\/ul>\n<\/td>\n
\n
    \n
  • Treatment-resistant<\/li>\n<\/ul>\n

    depression<\/p>\n

      \n
    • Major depressive disorder<\/li>\n
    • Terminal cancer-related<\/li>\n<\/ul>\n

      anxiety<\/p>\n

        \n
      • Obsessive compulsive<\/li>\n<\/ul>\n

        disorder<\/p>\n

          \n
        • Alcohol and nicotine<\/li>\n
        • dependence<\/li>\n<\/ul>\n<\/td>\n
\n